Janney Capital Management LLC Reduces Position in Stryker Co. (NYSE:SYK)

Janney Capital Management LLC lowered its position in Stryker Co. (NYSE:SYKFree Report) by 30.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 800 shares of the medical technology company’s stock after selling 350 shares during the quarter. Janney Capital Management LLC’s holdings in Stryker were worth $240,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also modified their holdings of the business. Farmers & Merchants Trust Co of Chambersburg PA grew its position in Stryker by 203.3% during the 4th quarter. Farmers & Merchants Trust Co of Chambersburg PA now owns 91 shares of the medical technology company’s stock worth $27,000 after purchasing an additional 61 shares during the last quarter. Rogco LP purchased a new stake in Stryker during the 4th quarter valued at approximately $30,000. HBC Financial Services PLLC acquired a new stake in Stryker during the 4th quarter worth approximately $37,000. Bourgeon Capital Management LLC purchased a new position in shares of Stryker in the 4th quarter valued at approximately $37,000. Finally, Operose Advisors LLC increased its holdings in shares of Stryker by 308.6% in the third quarter. Operose Advisors LLC now owns 143 shares of the medical technology company’s stock valued at $39,000 after purchasing an additional 108 shares during the period. 77.09% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Stryker

In other Stryker news, CAO William E. Berry, Jr. sold 7,690 shares of the business’s stock in a transaction dated Thursday, March 7th. The stock was sold at an average price of $358.48, for a total transaction of $2,756,711.20. Following the completion of the sale, the chief accounting officer now owns 3,675 shares of the company’s stock, valued at $1,317,414. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 5.50% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the stock. Canaccord Genuity Group upgraded shares of Stryker from a “hold” rating to a “buy” rating and set a $360.00 price objective for the company in a research report on Wednesday, January 31st. Roth Mkm increased their target price on Stryker from $348.00 to $405.00 and gave the stock a “buy” rating in a research note on Wednesday, May 1st. BTIG Research lifted their price target on Stryker from $366.00 to $369.00 and gave the company a “buy” rating in a research note on Wednesday, May 1st. TD Cowen increased their price objective on Stryker from $365.00 to $400.00 and gave the stock a “buy” rating in a research report on Thursday, April 11th. Finally, Robert W. Baird boosted their target price on shares of Stryker from $367.00 to $378.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 1st. Four equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $365.94.

View Our Latest Stock Analysis on SYK

Stryker Trading Up 2.4 %

Shares of SYK stock traded up $7.69 during mid-day trading on Wednesday, hitting $331.99. 1,760,233 shares of the company’s stock were exchanged, compared to its average volume of 1,340,421. The stock has a market cap of $126.47 billion, a price-to-earnings ratio of 37.70, a PEG ratio of 2.53 and a beta of 0.91. The company has a quick ratio of 0.99, a current ratio of 1.71 and a debt-to-equity ratio of 0.56. Stryker Co. has a fifty-two week low of $249.98 and a fifty-two week high of $361.41. The stock has a 50-day simple moving average of $343.60 and a two-hundred day simple moving average of $321.17.

Stryker (NYSE:SYKGet Free Report) last posted its quarterly earnings data on Tuesday, April 30th. The medical technology company reported $2.50 EPS for the quarter, beating analysts’ consensus estimates of $2.36 by $0.14. Stryker had a net margin of 16.03% and a return on equity of 23.05%. The company had revenue of $5.24 billion during the quarter, compared to the consensus estimate of $5.10 billion. During the same quarter in the prior year, the company posted $2.14 EPS. The company’s quarterly revenue was up 9.7% compared to the same quarter last year. Equities analysts expect that Stryker Co. will post 11.94 EPS for the current fiscal year.

Stryker Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 31st. Stockholders of record on Friday, June 28th will be paid a dividend of $0.80 per share. The ex-dividend date of this dividend is Friday, June 28th. This represents a $3.20 annualized dividend and a dividend yield of 0.96%. Stryker’s dividend payout ratio is presently 36.53%.

Stryker Profile

(Free Report)

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.

Read More

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE:SYKFree Report).

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.